Press release
Insomnia Market Expected to Reach $5,488 Million, globally, by 2023
Early buyers will receive 20% customization on this report.
Insomnia is a sleep disorder where in people have problem in falling asleep or remaining asleep. The major causes of insomnia include high stress level, mental disorders, excessive consumptions of caffeine & alcohol, and other medical conditions. Insomnia is categorized into three types depending on the duration of the disorder, namely transient (few days), acute (few weeks), and chronic insomnia (few months or even years).
Access full summary at: https://www.alliedmarketresearch.com/insomnia-market
The global insomnia market is driven by factors such as emergence of therapeutics with fewer side-effects and rise in demand for over-the-counter (OTC) sleep aids. Few drugs that are used for the treatment of chronic diseases affect the quality of sleep; thereby, increasing the number of insomnia cases. Furthermore, rise in geriatric population and growth in disposable income are expected to boost the market growth. However, the side-effects caused due to excessive use of sleep medication and patent expiration of many prescription drugs are expected to hamper the market growth.
Get PDF of this Report @ https://www.alliedmarketresearch.com/request-sample/2373
The pharmacological therapy segment is the highest contributor to the market growth. The non-pharmacological therapy segment is anticipated to be lucrative for market players, as these therapies cause fewer side effects as compared to drugs.
In 2016, North America accounted for the maximum contribution to the total revenue generated, owing to the high prevalence rate of insomnia, presence of high disposable income, and high demand for over-the-counter (OTC) drugs. In addition, the presence of large number of insomnia centers in this region and rise in the number of patients with chronic renal & kidney diseases are expected to boost the market growth. However, Asia-Pacific is expected to witness the highest CAGR during the study period, owing to increase in the number of people working at odd hours, rise in incidence rate of insomnia, and growth in disposable income.
Key Findings of the Insomnia Market:
• The cognitive behavioral therapy segment is anticipated to grow at the highest rate during the analysis period.
• The prescription drugs segment generated the highest revenue, and is expected to continue its dominance in the near future.
• North America dominated the global insomnia market, and is anticipated to continue its dominance in the future.
• China is expected to grow at highest CAGR in the Asia-Pacific.
• The pharmacological therapy segment was the largest contributor to the market growth, in 2016.
The key companies profiled in the report include Merck & Co. Inc., Sanofi India Limited, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, and ECR Pharmaceuticals.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact Us
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
E-mail: sales@alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Market Expected to Reach $5,488 Million, globally, by 2023 here
News-ID: 651742 • Views: …
More Releases from Allied Market Research
Mobile Application Security Market Growing at 26.3% CAGR Reach USD 37.1 Billion …
Allied Market Research published a new report, titled, "Mobile Application Security Market Growing at 26.3% CAGR Reach USD 37.1 Billion by 2032." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine…
MarTech Market Witnessing CAGR of 18.5% Hit USD 1.7 Trillion by 2032
The global marketing technology market is experiencing growth due to several factors, including the increasing digital transformation, the surge in demand for personalized experience, and the proliferation of automation and efficiency. However, data privacy and compliance, and the high cost of implementation are expected to hamper market growth. Furthermore, the growing integration of AI and ML technologies and the increase in demand for real-time marketing are anticipated to provide lucrative…
Feedback Management Software Market Growing with CAGR of 12.9% Reach USD 28.7 Bi …
Allied Market Research published a new report, titled, "Feedback Management Software Market Growing with CAGR of 12.9% Reach USD 28.7 Billion by 2031 ." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and…
Digital Educational Publishing Market Growing at 15.9% CAGR Reach USD 41.5 Billi …
The Market report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for the sustainable growth and gaining competitive edge in the market.
The global Digital Educational Publishing Market was valued at $9.9 billion in 2021, and is projected to reach $41.5 billion by 2031, growing at…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
